3 Marijuana Stocks That Could Be Millionaire-Makers

Any stock theoretically holds the potential to make you a millionaire. But few actually do. Stocks with the greatest likelihood of building fortunes tend to have small market caps and huge market opportunities.

Cannabis definitely offers a huge market opportunity. The global cannabis market could expand close to tenfold over the next 10 to 15 years. Many players in the cannabis industry remain small and…

have a lot of room to grow as the market opportunities unfold. Which marijuana stocks can investors buy right now that hold the potential to be millionaire-makers? Here are three that I think are at the top of the list.

1. Valens

Valens (OTC:VLNCF) is a virtual lock to profit in a big way as the global cannabis market expands, in my view. The company provides services to extract cannabinoids such as CBD and THC from cannabis plants.

It’s a pretty safe bet that the demand for cannabis extraction will soar over the next few years. The Cannabis 2.0 cannabis derivatives market in Canada is just getting started. Products including cannabis-infused beverages and foods as well as vapes are expected to rack up billions of dollars in sales. In the U.S., the legalization of hemp in late 2018 should drive increased demand for products containing hemp-derived CBD.

Valens is set to be a major winner in Canada’s Cannabis 2.0 market and could make significant headway into the U.S. market, too. It boasts the highest extraction capacity in the industry. The company’s customers include many of the biggest names in the business —Canopy GrowthHEXOOrganigram (NASDAQ:OGI)Tilray, and more. With a market cap of around $350 million, I think that Valens should deliver massive returns over the next decade.

2. Organigram

One of Valens’ customers should also achieve tremendous success in the not-too-distant future. Organigram isn’t the largest cannabis producer in Canada, but it’s arguably the best.

Most of the major Canadian cannabis producers are struggling to establish a clear path to profitability. Organigram, though, appears to be in a good position to become profitable after its stellar fiscal 2020 first-quarter results announced a few weeks ago. The company’s low cultivation costs and fiscal discipline put Organigram in the top tier of cannabis producers. Its market cap of around $450 million — lower than most of its key rivals — makes Organigram a better bargain.

Several factors should fuel Organigram’s growth. The company’s sales should soar as the Cannabis 2.0 market in Canada picks up steam. Ontario, Canada’s most heavily populated province, is opening more retail stores throughout 2020. I also wouldn’t be surprised if a large consumer packaged goods company partners with Organigram, opening the door for…

Continue reading at THE MOTLEY FOOL

 

 

 

You May Also Like

About the Author: admin

Leave a Reply

Your email address will not be published.